Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.52 |
| ▸ | HMGCR | P04035 | 3/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129776 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL130214 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL9361038 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448226 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL128297 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448860 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448474 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL128390 | 1.00 | — | — | |
| SCHEMBL130583 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL31423438 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0365149-A2 | Leukotriene antagonist prodrugs | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-25 | — | — | EP | claimed |
| EP-2300224-B1 | ARTICLES CONTAINING FUNCTIONAL POLYMERIC PHASE CHANGE MATERIALS AND METHODS OF MANUFACTURING THE SAME | OUTLAST TECH GMBH (DE) | 2024-09-11 | — | — | EP | disclosed |
| EP-2300658-B1 | HEAT REGULATING ARTICLE WITH MOISTURE ENHANCED TEMPERATURE CONTROL | OUTLAST TECH GMBH (DE) | 2024-08-14 | — | — | EP | disclosed |
| US-20240125678-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2024-04-18 | — | — | US | disclosed |
| WO-2024053316-A1 | COMPOUND, EXTRACELLULAR VESICLE STAINING AGENT, AND FLUORESCENT STAINING METHOD FOR EXTRACELLULAR VESICLES | 国立大学法人東海国立大学機構 | 2024-03-14 | — | — | WO | disclosed |
| EP-4286388-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | National University Corporation Tokai National Higher Education and Research System (JP) | 2023-12-06 | — | — | EP | disclosed |
| EP-2362830-B1 | MICROCAPSULES AND OTHER CONTAINMENT STRUCTURES FOR ARTICLES INCORPORATING FUNCTIONAL POLYMERIC PHASE CHANGE MATERIALS | OUTLAST TECH GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| EP-2883865-B1 | Compound capable of binding S1P receptor and pharmaceutical use thereof | ONO PHARMACEUTICAL CO (JP) | 2019-09-25 | — | — | EP | disclosed |
| EP-2740724-B1 | COMPOUND FOR TREATING CARTILAGE DISORDERS | ONO PHARMACEUTICAL CO (JP) | 2016-12-28 | — | — | EP | disclosed |
| EP-2657229-B1 | BENZYLOXYPYRIMIDINE DERIVATIVE, AGRICULTURAL/HORTICULTURAL INSECTICIDE COMPRISING SAID DERIVATIVE AND METHOD FOR USING THE SAME | NIHON NOHYAKU CO LTD (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-5719176-A | 2-amino-1,3-propanediol compound and immunosuppressant | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-02-17 | — | — | US | disclosed |
| US-5646273-A | FOR USE IN OPTICAL DISKS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-07-08 | — | — | US | disclosed |
| EP-0781827-A1 | Liquid crystal mixture and liquid crystal device comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-02 | — | — | EP | disclosed |
| US-5604229-A | 2-amino-1,3-propanediol compound and immunosuppressant | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-02-18 | — | — | US | disclosed |
| EP-0709444-A1 | Liquid crystal mixture and liquid crystal device comprising the same | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0627406-A1 | 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0619345-A1 | Phthalocyanine compound and optical recording medium containing it | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-10-12 | — | — | EP | disclosed |
| EP-0365149-A3 | LEUKOTRIENE ANTAGONIST PRODRUGS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-07-25 | — | — | EP | disclosed |
| EP-0365149-A2 | Leukotriene antagonist prodrugs | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-25 | — | — | EP | disclosed |
| EP-0365149-A2 | Leukotriene antagonist prodrugs | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240125678-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | EXOSC4, EXOSC5, EXOSC9 | PTPN7 4035/4885HMGCR 3221/4885RECQL 1783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.